HeartFlow Ownership & Insider Activity

HeartFlow (HTFL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.7% of shares outstanding. Institutional investors hold 61.8%. Over the past 90 days, insiders made 11 sales worth $12.4M.

Shares Outstanding

86.954M

Shares Float

60.107M

Insider Shares Owned

1.504M

Insider % Owned

1.7%

Institutional Shares Held

53.753M

Institutional % Held

61.8%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$12.4M total

Net Activity

Net Selling

Net Value (90d)

-$12.4M

HeartFlow Insider Transactions (Last 6 Months)

Ver todas las transacciones con información privilegiada →

Date	Insider	Title	Type	Shares	Price	Value
Sep 18, 2026	Campbell Rogers	CHIEF MEDICAL OFFICER	SELL	6.503K	$29.04	$882K
Sep 17, 2026	Vikram Verghese	CHIEF FINANCIAL OFFICER	SELL	24.345K	$50.55	$1.2M
Sep 11, 2026	Vikram Verghese	CHIEF FINANCIAL OFFICER	SELL	34.975K	$50.08	$1.8M
Sep 10, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	38.900K	$46.78	$1.8M
Sep 8, 2026	Vikram Verghese	CHIEF FINANCIAL OFFICER	SELL	6.640K	$50.03	$332K
Sep 2, 2026	Vikram Verghese	CHIEF FINANCIAL OFFICER	SELL	33.416K	$49.85	$1.7M
Aug 21, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	27.230K	$50.00	$1.4M
Aug 18, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	32.676K	$45.00	$1.5M
Aug 17, 2026	Campbell Rogers	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$30.11	$205K
Aug 14, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	15.560K	$39.06	$608K
Aug 10, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	22.562K	$28.31	$639K
Jul 15, 2026	Campbell Rogers	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$22.36	$62K
Jul 10, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	22.562K	$27.75	$626K
Jun 24, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	38.900K	$35.00	$1.4M
Jun 10, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	22.562K	$28.50	$643K
May 18, 2026	Campbell Rogers	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$23.67	$86K
May 11, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	22.562K	$29.12	$657K
Apr 28, 2026	Bain Capital Life Sciences Investors LLC, Bain Capital Life Sciences III General Partner LLC, Bain Capital Life Sciences Fund III LP, BCLS Fund III Investments GP LLC, BCLS Fund III Investments LP	—	SELL	2.000M	$29.45	$58.9M
Apr 10, 2026	CM John Farquhar	CHIEF EXECUTIVE OFFICER	SELL	22.562K	$26.72	$603K
Apr 1, 2026	Campbell Rogers	CHIEF MEDICAL OFFICER	SELL-OPTIONS	2.484K	$13.44	$1.4M

More with Benzinga EdgeGet Access

HeartFlow Inc

HeartFlow Ownership & Insider Activity

HeartFlow Insider Transactions (Last 6 Months)

People Also Watch

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

People Also Watch